AONC (AON) Yalpi foyda bo'yicha sotuv rentabelligi

AONC (American Oncology Network, Inc.) - kompaniyaning tovar belgisi

Sug'urta shartnomalari uchun sog'liqni saqlash gigantlari bilan raqobat joriy yalpi marjada aks etgan bosimni yuzaga keltirmoqda. 4.20 qiymati ushbu ko'rsatkichning joriy miqdorini belgilaydi. American Oncology Network (AONC) barqarorligi yagona IT platformasi va dorixona tarmog'iga asoslangan. Biznes samaradorligi malakali onkologlarni faol jalb qilish va ichki treninglar orqali ta'minlanadi, bu esa ishchi kuchining yetishmasligini qoplaydi.

American Oncology Network, Inc. (AONC): Yalpi marja 21.02.2024dan 04.08.2024gacha

AON (AONC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning asosiy tahlili:AONC aoncology.com
American Oncology Network Inc brendining mahsuloti

Aktivlar sifati va bozor qiymati o'rtasida muvozanatni topish uchun, tushumning bevosita operatsion xarajatlar chegirib tashlangan qismini o'lchovchi yalpi foyda marginini tahlil qilish American Oncology Network (AONC) uchun juda muhimdir. Tarmoqning biznes modeli doirasida ushbu ko'rsatkich mustaqil klinikalarning dorixona va laboratoriya xaridlarini markazlashtirish samaradorligini aks ettiradi. Yalpi foyda margini tendentsiyalari investorlarga barqaror daromadli o'sishni qisqa muddatli bozor tebranishlaridan ajratish imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik